BARLOW CARROLEE received a stock award from SUPERNUS PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/24/2023ACC: 0001104659-23-025377
Director
Since Jun 2018
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
3.88K acquired · 3.88K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+3.88K
Price / share
—
Trade value
—
% of position
41.2%
2/22/2023
9.43K→13.31K
Total
Net shares
+3.88K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/22/2023 | A · Award | +3.88K | — | — | 41.2% | 9.43K | 13.31K |
| Total | +3.88K | $0.00 | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
3.88K shares
Shares
−3.88K
Strike price
Held after
0.00
Exercisable
—
2/22/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock3.88K shares | 2/22/2023 | D · Disposition | −3.88K | — | 0.00 |